Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Total Liabilities: 2021-2025

Historic Total Liabilities for Roivant Sciences (ROIV) over the last 5 years, with Mar 2025 value amounting to $249.7 million.

  • Roivant Sciences' Total Liabilities fell 58.92% to $257.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $257.1 million, marking a year-over-year decrease of 58.92%. This contributed to the annual value of $249.7 million for FY2025, which is 67.73% down from last year.
  • Roivant Sciences' Total Liabilities amounted to $249.7 million in FY2025, which was down 2.59% from $256.4 million recorded in FY2024.
  • Over the past 5 years, Roivant Sciences' Total Liabilities peaked at $782.0 million during FY2023, and registered a low of $249.7 million during FY2025.
  • Its 3-year average for Total Liabilities is $558.0 million, with a median of $728.1 million in 2023.
  • Its Total Liabilities has fluctuated over the past 5 years, first spiked by 49.33% in 2023, then tumbled by 67.73% in 2025.
  • Over the past 5 years, Roivant Sciences' Total Liabilities (Yearly) stood at $527.7 million in 2021, then reached $529.6 million in 2021, then dropped by 0.76% to $523.7 million in 2022, then spiked by 46.49% to $775.8 million in 2022, then soared by 49.33% to $782.0 million in 2023, then declined by 6.15% to $728.1 million in 2023, then declined by 1.03% to $774.0 million in 2024, then tumbled by 64.79% to $256.4 million in 2024, then tumbled by 67.73% to $249.7 million in 2025.